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Abstract 
The aim of the present study was to evaluate the efficacy of the vacuum–assisted closure 
(V.A.C.) system in the treatment of early hip joint infections. 28 patients (11 m / 17 f; mean 
age 71 y. [43-84]) with early hip joint infections have been treated by means of the 
V.A.C.-therapy. At least one surgical revision [1–7] has been unsuccessfully performed for 
infection treatment prior to V.A.C. – application. Pathogen organisms could have been iso-
lated in 22/28 wounds. During revision, cup inlay and prosthesis head have been exchanged 
and 1-3 polyvinylalcohol sponges inserted into the wound cavity/ periprosthetically at an ini-
tial continuous pressure of 200 mm Hg. Postoperatively, a systemic antibiosis was given ac-
cording to antibiogram. 48-72 h after surgery an alteration from haemorrhagic to serous 
fluid was observed in the V.A.C.-canister. Afterwards, the pressure was decreased to 150 
mm Hg and remained at this level till sponge removal. After a mean period of 9 [3–16] days 
the inflammation parameters have been retrogressive and the sponges were removed. An 
infection eradication could be achieved in 26/28 cases. In the two remaining cases the in-
fected prosthesis had to be explanted and a gentamicin-vancomycin-loaded spacer has been 
implanted, respectively. At a total mean follow-up of 36 [12-87] months no reinfection or 
infection persistence was observed. The V.A.C.-system can be a valuable contribution in the 
treatment of early joint infections when properly used. Indications should be early infections 
with well-maintained soft-tissues for retention of the negative atmospheric pressure. 
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Introduction 
In spite of numerous prophylactic measures in-
fections after primary total hip arthroplasty (THA) 
still occur in 0.5 - 1.4 % of the cases [4]. Generally, joint 
infections are categorised in early (within 6 weeks 
after surgery) and late infections (> 6 weeks) [15]. Ef-
forts for infection management in early cases with 
prosthesis preservation include debridement, necro-
sectomy, pulsatile lavage, insertion of antibi-
otic-loaded device (PMMA-beads, collagen sponges) 
or flush-suction drain [15]. Should these methods be 
unsuccessful, a one-stage procedure is usually carried 
out [1, 15]. Hereby, the infected prosthesis is removed, 
debridement and jet lavage of the infected area are 
performed and a new endoprosthesis is reimplanted 
at the same time. In most of these cases the infection 
management consists of systemic antibiosis and anti-
biotic-loaded bone cement for fixation of the prosthe-
sis. The patient is not endangered by the risks of ad-
ditional surgeries, and the success rates are reportedly 
between 80-85 % [15]. 
However, in case of a surgical revision with 
prosthesis retention, one of the major problems might 
be wound healing complications with a persistent 
draining sinus despite revision. In multiple surgical Int. J. Med. Sci. 2009, 6 
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fields the vacuum-assisted closure (V.A.C.) has been 
established as an efficient treatment option even for 
deep wound infections. The most important advan-
tages of this system are an increased localised blood 
flow, the reduction of tissue bacterial counts, elimina-
tion of interstitial edema and the safe fluid flow in a 
closed system [2]. Furthermore, the structure of the 
sponges and the altered pressure environment in the 
wound stimulate the proliferation of granulation tis-
sue [2]. However, although the V.A.C.-therapy cor-
responds with the concept of infection treatment with 
implant/prosthesis preservation, it is not often used 
in orthopaedic surgery.  
In this study, we report our experience on the 
management of bacterial infections and/or draining 
sinus of the hip joint by means of the V.A.C. - therapy. 
Patients-Methods 
Between 2000 and 2007, 66 patients with early 
infections after various hip joint surgeries (Fig. 1) have 
been treated in our department. In 38 cases, an infec-
tion eradication could be achieved after a single revi-
sion, consisting of hematoma removal, pulsatile lav-
age and insertion of gentamicin-loaded collagen 
sponges. The remaining 28 patients (11 male/ 17 fe-
male; mean age 71 y. [43 - 84]) have been treated by 
means of V.A.C.-therapy (Table 1). In all cases, at least 
one surgical revision [1 – 7] has been performed for 
infection treatment prior to V.A.C. – application 
without success. Pathogen organisms could have been 
isolated in 22/28 wounds. All data about the patients, 
primary surgical procedures, revisions and follow- up 
are shown in Table 1. 
 
Table 1: Patient’s data, surgical procedures and causative organisms. 
Patient 
  
  
  
  
Age / 
Gender 
  
Primary 
surgery 
  
  
  
Pathogen 
organism(s) 
  
Time period 
between 
prim. surgery 
and revision 
[weeks] 
Time period 
of V.A.C. 
implantation 
[days] 
  
Revisions 
prior to V.A.C. 
implantation 
  
  
Follow-up 
[months] 
  
1  81/ M  aseptic cup  S. marcescens  3  11  2  68 
     loosening  CN staphylococci           
         gram(-) rods             
2 51/  F  Girdlestone  E.  faecalis  10  13  4  45 
3 46/  M  spacer  MRSA  3  8  7  87 
      implantation                
4 54/  F  spacer  MRSA  4  11  2  82 
      implantation                
5 49/  F  Girdlestone  E.  faecalis  7  8  3  67 
6  71/ F  aseptic cup  gram (+) anaerobes  5  11  1  44 
     loosening  P. magnus           
         S. epidermidis             
7  84/ M  THA after spacer  S. simulans  3  8  1  43 
      implantation                
8  82/ F  aseptic cup  S. epidermidis  1  13  1  42 
      loosening                
9  69/ M  primary THA    S. epidermidis  3  16  1  35 
10  51/ F  aseptic cup  Enterobacteriae  3  12/11/13  1  36 
     loosening  S. epidermidis           
        C. albicans           
        MRSA           
11  83/ F  primary THA    E. coli  4  12  2  32 
12  52/ F  THA after spacer  S. epidermidis  5  11  2  32 
     implantation             
13  71/ F  THA after spacer  P. vulgaris  2  11  1  32 
      implantation  E. cloacae             
14  57/ M  primary THA    CN staphylococci  3  12  1  42 
15  73/ M  THA after spacer  no bacterium identified  2  9  1  42 
      implantation                
16  73/ F  primary THA    S. epidermidis  5  10/3/7  1  42 
        K. pneumoniae           
17  65/ M  primary THA    no bacterium identified  4  9  1  42 
18  49/ F  primary THA    S. aureus  4  7  2  35 
        C. albicans           
19  71/ M  primary THA    E. faecalis  1  7/9  1  30 
20  79/ F  primary THA    S. aureus  7  7  1  30 Int. J. Med. Sci. 2009, 6 
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21  72/ F  aseptic stem  S. epidermidis  2  6  1  25 
      loosening                
22  70/ F  primary THA    E. faecalis  2  4/9  1  23 
        K. pneumoniae           
        P. mirabilis           
23  72/ F  aseptic stem  E. faecalis  2  8  1  20 
      loosening                
24  72/ M  resection of het-
erotopic ossification 
after primary THA  
no bacterium identified  2  8  1  20 
25  66/ F  tumour prosthesis  no bacterium identified  4  7/5  1  17 
26  43/ M  primary THA    S. aureus  4  5  1  15 
27  79/ F  spacer  no bacterium identified  2  8  1  13 
      implantation                
28  67/ M  spacer  no bacterium identified  2  9  1  12 
     implantation             
 
 
Our operative concept always began by injecting 
methylene blue into the fistula in order to define the 
areas of necessary debridement and lavage (Fig. 2). 
The surgical approach was chosen according to the 
surgeon’s preferences or along the pre-existing sur-
gical approach. All tissue layers were anatomically 
prepared until reaching the wound/resection cavity 
or the prosthesis. Meticulous debridement of all ne-
crotic and infected tissues and jet lavage with 10 l 
Ringer solution PL 2511 (Fresenius-Kabi, 
B a d - H o m b u r g ,  G e r m a n y )  w e r e  p e r f o r m e d .  I f  p o s s i -
ble, cup inlay and prosthesis head were exchanged 
(Fig. 3). 1-3 polyvinylalcohol (PV) sponges have been 
placed either around the prosthesis stem or into the 
resection cavity (Fig. 4) with a transcutan tube out-
going. We chose the PV sponges instead of the poly-
urethane ones because they cause less pain and can be 
left in situ for a longer time period. The wounds have 
been closed in layers under meticulous reconstruction 
and accurate adaptation of the tissue layers (Fig. 5-6). 
One redon drain has been placed subcutaneously. 
Postoperatively, a continuous subatmospheric pres-
sure of 200 mm Hg has been initially attached to the 
wound via V.A.C.® ATS (KCI, Medizinprodukte 
GmbH, Walluf, Germany).  
After infection eradication (defined by the clini-
cal course, laboratory parameters and inspection of 
the drained fluid by the V.A.C. – system) the V.A.C. 
sponges were removed. After pulsatile lavage, 1-2 
gentamicin-loaded collagen sponges were inserted 
into the wound. One redon drain was placed around 
the prosthesis or into the wound cavity and another 
was placed subfascial.  
Postoperatively, all patients have been treated 
with systemic antibiosis according to antibiogram for 
the first 2 weeks followed by an oral antibiosis for 
another 2 weeks. In cases without germinal proof, a 
broad spectrum antibiosis (cefuroxime + clindamycin) 
has been applied.  
 
Figure 1: Draining sinus 3 weeks after total hip arthro-
plasty. 
 
 
 
Figure 2: Injection of methylene blue into the fistula for 
identification of all infected tissues. Int. J. Med. Sci. 2009, 6 
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Figure 3: Cup inlay and prosthesis head should be re-
moved on routine. 
 
 
Figure 4: Periprosthetical insertion of polyvinylalcohol 
sponges. 
 
 
Figure 5: Anatomical reconstruction and adaptation of the 
tissue layers for retention of the V.A.C. – therapy. 
 
Figure 6: The wound is closed, the tubes are transcuta-
neously lead out. 
 
Results 
48-72 h after surgery an alteration from haem-
orrhagic to serous fluid could be observed in the 
V.A.C. - canister. Afterwards, the continuous pressure 
was decreased to 150 mm Hg and remained at this 
level until sponge removal. After a mean period of 9 
[3 – 16] days the inflammation parameters (C-reactive 
protein (CRP), erythrocyte sedimentation rate (ESR), 
leucocytes blood count) were retrogressive, and the 
wound secretion was obviously reduced so that we 
were able to plan the surgical removal of the sponges. 
At this point, we accurately debrided the skin parts of 
the tubes exit holes. In cases with a macroscopically 
not clean operative situs, the sponges were only ex-
changed and tissue samples as well as parts of the 
removed V.A.C sponges were sent for further micro-
biological examination. No complications were ob-
served during the sponges’ removal, independent on 
the implantation period. At sponges removal, tissues 
samples sent for microbiological examination were 
negative in 26/28 cases. At a mean follow-up of 36 [12 
– 87] months no reinfections occurred (Fig. 7). 
Complications were observed in three cases. In 
case no. 2, it was necessary to remove the sponges 
after 8 days due to a postoperative haemorrhagia and 
consecutive coagulation complications caused by liver 
cirrhosis and consecutive thrombocytopenia. How-
ever, there was no negative influence on the remain-
ing therapy progress with regard to the infection 
sanitation. In cases no. 10 and 16, the infection per-
sisted so that the endoprosthesis had to be removed 
and a gentamicin-vancomycin-impregnated PMMA 
spacer (1 g gentamicin/ 4 g vancomycin/ 80 g 
PMMA) was implanted, respectively. 3 months later, Int. J. Med. Sci. 2009, 6 
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no local or systemic signs of infection could be de-
tected. A prosthesis reimplantation was performed in 
both cases. At a further follow-up of 30 and 32 
months, respectively, no reinfection or infection per-
sistence could be observed.  
 
 
 
Figure 7: Outcome 3 months after V.A.C. – therapy. 
 
Discussion 
Joint infections are still a hazardous problem in 
orthopaedic surgery. Infections after total hip re-
placement are based on the bacterial colonisation on 
the surface area of an endoprosthesis involving the 
local tissue and causing an immune reaction [15]. The 
most common problem hereby is the draining sinus, 
prolongating and preventing wound healing. The 
pathophysiological mechanisms are the emergence of 
interstitial edema, disturbed microcirculation and 
bacterial contamination, usually leading to prosthesis 
explantation [15]. 
Morykwas et al. have demonstrated that the ap-
plication of the V.A.C. – system increased the granu-
lation tissue formation and the local blood flow, and 
enhanced the bacterial clearance function [13]. Since 
interstitial edema is eliminated without any impact on 
systemic haemodynamics, the surrounding tissue is 
decompressed and local microcirculation is 
re-established. The increase of the oxygen gradient 
facilitates the transportation of toxins and inhibitors 
inducing thereby the wound healing [16]. As a result 
of the increased angiogenesis, the local antibiotic 
concentrations are increased, too [3, 11]. Last but not 
least, the transport of cellular and humoral compo-
nents of the immune system to the infected area is 
facilitated, which leads to a significant reduction of 
the bacterial count. 
The efficacy of the V.A.C. therapy has been 
proven in the treatment of wound infections. 
Fleischmann et al. could show that exposed implants 
can be preserved by V.A.C.-application and an over-
growth of granulation tissue can be observed [5]. 
Despite its advantages as granulation tissue forma-
tion, safe wound fluid flow and bacteria count reduc-
tion, the V.A.C.-system is not often used in the treat-
ment of prosthesis – related infections. 
Currently, there exist only four reports about the 
use of the V.A.C. – system in the infection manage-
ment after total knee or hip arthroplasty. Interest-
ingly, all of them have used only polyvinylalcohol 
sponges for infection management. Kelm et al. re-
ported an infection eradication in 9 out of 10 patients 
having early infections after total hip or excision ar-
throplasty by means of the conventional 
V.A.C.-system at a mean follow-up of 21 months [6]. 
Kirr et al. showed good results in 3 cases by using the 
V.A.C.-Instill® system in the treatment of early infec-
tions after total hip replacement (follow-up not re-
ported) [7]. Lehner and Bernd made similar observa-
tions with the V.A.C.-Instill® system in 2 cases at a 
follow-up of 8 and 22 weeks, respectively [10]. 
Lüdemann et al. treated 17 cases of early infections 
after THA by insertion of polyvinylalcohol sponges 
[12]. An infection persistence or reinfection was seen 
in 8 cases (47 %; follow-up not reported), however, the 
authors defined early infections as those within the 
first postoperative year and not within the first six 
postoperative weeks. 
To our knowledge, our patient collective is the 
largest one having been treated by means of the 
V.A.C.-therapy at the site of an early hip joint infec-
tion. We believe that the careful patients’ selection as 
well as the modified technique is responsible for the 
good outcome. In the usual V.A.C. – technique, the 
sponges are fixed on wound areas by a sterile self 
adhesive foil. In contrast to that, we insert the sponges 
either periprosthetically or into the resection cavity. 
Hereby, intact soft-tissues are an indispensable 
premise for emergence and retention of the vacuum. 
The tubes supporting the subatmospheric pressure 
applied are transcutaneously led out. Then the wound 
is closed. In order to achieve a bacterial count reduc-
tion, the following requirements have to be met: me-
ticulous debridement of the tissue [16-17], mechanical 
cleaning and lavage of the exposed prosthesis parts. 
Moreover, we advance the view that an adequate 
wound closure can only be performed after an exact 
anatomical preparation and mobilisation of the tissue 
layers. This anatomical preparation and the resulted 
reconstruction of the soft-tissue layers may allow an 
enhanced biomechanical function for the postopera-
tive clinical outcome. Hereby, the tissue blood flow is Int. J. Med. Sci. 2009, 6 
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optimised, thus contributing to infection sanitation 
[11]. Further advantages of our procedure are the less 
extensive bandage changing, with a positive influence 
on the patient´s convenience [16] and the possibility of 
costs minimization [8, 14]. The disadvantage of lack-
ing inspections of the sponges can be compensated by 
daily controlling of the canister fluid and monitoring 
of the inflammation parameters.  
Our clinical outcome with a success rate in 26 out 
of 28 cases after a mean follow-up of 3 years indicates 
that the V.A.C.-therapy can be a valuable contribution 
to the treatment of early hip joint infections. However, 
indications for V.A.C. application should be strictly 
made. If a vacuum cannot be developed due to skin 
and tissue lesions or necroses, then the 
V.A.C.-therapy should not be used for infection 
management of the underlying implant. Moreover, 
the virulence of the causative pathogens, the severity 
of infection and the host response to antimicrobial 
treatment are parameters to bear in mind when 
V.A.C.-therapy is elected for infection management. 
Multimicrobial infections, including bacteria and 
fungi [9], seem to overstrain the clearance function of 
the V.A.C.-therapy, thus being probably the reason 
for the system failure in the infection treatment in case 
10. 
O n e  l i m i t a t i o n  o f  o u r  s t u d y  i s  t h a t  w e  c a n n o t  
define the ideal frequency for sponge exchange since 
there exists no consensus regarding the use of the 
V.A.C. – therapy in orthopaedic surgery. Most con-
cepts are based on subjective experiences gained over 
the years. Moreover, it is unknown whether the 
polyurethane sponges of the V.A.C. – system would 
have the same outcome as the polyvinylalcohol 
sponges did in the present study. Equally to that, our 
results account only for an initial pressure of -200 mm 
Hg with a reduction after 2-3 days to -150 mm Hg. It is 
unknown if other pressure heights would have a 
similar outcome. Moreover, our study does not have a 
control group treated by another regime. However, 
patients’ collectives suffering from joint infections are 
frequently so inhomogenous that a randomization is 
difficult, and therefore, the orthopaedic surgeon 
should treat each case individually. 
In conclusion, we recommend that the 
V.A.C.-therapy can be used in cases with prolonged 
draining sinus or early infections after total hip and 
excision arthroplasty. Intact soft-tissues are an indis-
pensable premise for development and retention of 
the vacuum. The patients’ comfort can be enhanced 
and the frequency of the bandages exchange reduced. 
However, its application in cases with high virulent 
organisms is arguable. Hereby, the creation of a 
therapy concept is essential with respect to the treat-
ment strategies of septic surgery and the causes of the 
infection. 
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